Discover 561 paid clinical trials in Richmond, Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 561
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Richmond VA, Washington D.C. DC, Durham NC,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06532279
Phase2, Recruiting
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
for
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements,
Location: Richmond VA, Charlottesville VA, Bethesda MD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06649812
Phase2, Recruiting
A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
for
CTCL
Location: Richmond VA, New Haven CT, Rochester NY, Boston MA,
Sponsor: Prescient Therapeutics, Ltd.
Sex: All
Age: 18+
Code: NCT06854653
Phase2, Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for
B Acute Lymphoblastic Leukemia
Location: Richmond VA, Charlottesville VA, Norfolk VA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 46
Code: NCT06124157
Phase2, Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
for
Recurrent Langerhans Cell Histiocytosis,
Location: Richmond VA, Charlottesville VA, Norfolk VA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 22
Code: NCT05828069
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
for
Pancreatic Carcinoma, Pancreatic Neoplasm
Location: Richmond VA, Quakertown PA, Allentown PA, Bethlehem PA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06807437
Phase3, Recruiting
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
for
Metastatic Head-and-neck Squamous-cell Carcinoma,
Location: Richmond VA, Washington D.C. DC, Baltimore MD,
Sponsor: AVEO Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06064877
Phase3, Recruiting
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
for
Castration-Resistant Prostate Carcinoma,
Location: Richmond VA, Mechanicsville VA, Midlothian VA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06632977
Phase2, Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
for
Advanced Malignant Solid Neoplasm,
Location: Richmond VA, South Hill VA, Charlottesville VA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0+
Code: NCT05564377
Phase2, Recruiting
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
for
Metastatic Salivary Gland Carcinoma,
Location: Richmond VA, Cumberland MD, York PA, Carlisle PA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT05408845
Phase2, Recruiting
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
for
Stage II Nasopharyngeal Carcinoma AJCC v8,
Location: Richmond VA, Charlottesville VA, Norfolk VA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 21
Code: NCT06064097
Phase2, Recruiting
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
for
Cutaneous Melanoma, Stage II
Location: Newport News VA, Richmond VA, Charlottesville VA,
Sponsor: Melanoma and Skin Cancer Trials Limited
Sex: All
Age: 18+
Code: NCT03860883
Recruiting
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
for
Prostate Cancer
Location: Richmond VA, Midlothian VA, Jefferson Hills PA,
Sponsor: Canadian Cancer Trials Group
Sex: Male
Age: 18+
Code: NCT06235697
Phase3, Recruiting
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
for
Biochemically Recurrent Prostate Carcinoma,
Location: Richmond VA, Charlottesville VA, Washington D.C. DC,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: Male
Age: 18+
Code: NCT04423211
Phase3, Recruiting
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma